[HTML][HTML] AI for managing open innovation: Opportunities, challenges, and a research agenda

T Broekhuizen, H Dekker, P de Faria, S Firk… - Journal of Business …, 2023 - Elsevier
Artificial intelligence (AI) provides ample opportunities for enabling effective knowledge
sharing among organizations seeking to foster open innovation. Past research often …

[HTML][HTML] Innovative robotic technologies and artificial intelligence in pharmacy and medicine: paving the way for the future of health care—a review

M Stasevych, V Zvarych - Big data and cognitive computing, 2023 - mdpi.com
The future of innovative robotic technologies and artificial intelligence (AI) in pharmacy and
medicine is promising, with the potential to revolutionize various aspects of health care …

ZINC-22─ A free multi-billion-scale database of tangible compounds for ligand discovery

BI Tingle, KG Tang, M Castanon… - Journal of chemical …, 2023 - ACS Publications
Purchasable chemical space has grown rapidly into the tens of billions of molecules,
providing unprecedented opportunities for ligand discovery but straining the tools that might …

[HTML][HTML] From traditional ethnopharmacology to modern natural drug discovery: A methodology discussion and specific examples

S Pirintsos, A Panagiotopoulos, M Bariotakis… - Molecules, 2022 - mdpi.com
Ethnopharmacology, through the description of the beneficial effects of plants, has provided
an early framework for the therapeutic use of natural compounds. Natural products, either in …

Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

PC Tiwari, R Pal, MJ Chaudhary… - Drug Development …, 2023 - Wiley Online Library
By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the
entire drug discovery process stands to undergo a profound transformation, offering a …

GPCNDTA: prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

L Zhang, CC Wang, Y Zhang, X Chen - Computers in Biology and Medicine, 2023 - Elsevier
Drug-target affinity prediction is a challenging task in drug discovery. The latest
computational models have limitations in mining edge information in molecule graphs …

Bat2: an open-source tool for flexible, automated, and low cost absolute binding free energy calculations

G Heinzelmann, DJ Huggins… - Journal of Chemical …, 2024 - ACS Publications
Absolute binding free energy (ABFE) calculations with all-atom molecular dynamics (MD)
have the potential to greatly reduce costs in the first stages of drug discovery. Here, we …

[HTML][HTML] User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals

O Kapustina, P Burmakina, N Gubina, N Serov… - Artificial Intelligence …, 2024 - Elsevier
Artificial intelligence has brought crucial changes to the whole field of natural sciences.
Myriads of machine learning algorithms have been developed to facilitate the work of …

Drug repurposing: An effective strategy to accelerate contemporary drug discovery

P Zhan, B Yu, L Ouyang - Drug discovery today, 2022 - pmc.ncbi.nlm.nih.gov
Because of the high risk, substantial cost and slow pace of new drug discovery and
development, drug repurposing (also called repositioning, redirecting, reprofiling) is …

Machine learning based dynamic consensus model for predicting blood-brain barrier permeability

B Mazumdar, PKD Sarma, HJ Mahanta… - Computers in Biology and …, 2023 - Elsevier
The blood-brain barrier (BBB) is an important defence mechanism that restricts disease-
causing pathogens and toxins to enter the brain from the bloodstream. In recent years, many …